- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche, alacizumab pegol (CDP 791) / UCB
[VIRTUAL] A Novel Nanobody: Capalacizumab, in the Modern Era of TTP Treatment (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_3063;
As with any novel treatments, further studies are indicated, especially those not funded by the drug manufacturer. Our patient did have a favorable response using capalacizumab in addition to steroids, rituximab, and plasmapheresis.
- |||||||||| Rituxan (rituximab) / Roche, Biogen, Zenyaku Kogyo, alacizumab pegol (CDP 791) / UCB
A Novel Nanobody: Capalacizumab, in the Modern Era of TTP Treatment (PENNSYLVANIA CONVENTION CENTER, Hall D-E (200 Level), Area G) - Mar 15, 2020 - Abstract #ATS2020ATS_5430;
As with any novel treatments, further studies are indicated, especially those not funded by the drug manufacturer. Our patient did have a favorable response using capalacizumab in addition to steroids, rituximab, and plasmapheresis.
|
